Cancer of Liver Clinical Trial
Official title:
Radiopaque Microsphere (Hydrophilic Series) for Hepatoma Embolization Therapy
The purpose of this study is to evaluate the safety and efficacy of Radiopaque Microsphere (T-ACE Beads) interventional therapy for patients with liver cancer
The study will evaluate the safety and tolerability of Taiwan ACE Beads used for
chemoembolization for the treatment of unresectable hepatocellular carcinoma.
The investigators will study the overall response rates of lesions with Taiwan ACE Beads. The
procedure is similar with conventional TACE (transcatheter arterial chemoembolization). At
the target vessels, radiologists will inject lipiodol with doxorubicin first, then Taiwan ACE
Beads instead of Gelfoam or PVA (polyvinyl alcohol). The end point of injection is also
similar with conventional TACE.
Determine the complication rates, progression free survival (PFS) and overall survival (OS)
following Taiwan ACE Beads embolization.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01627808 -
Fluid Optimization in Liver Surgery
|
N/A | |
| Withdrawn |
NCT05109052 -
Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05179824 -
Tempus Priority Study: A Pan-tumor Observational Study
|
||
| Recruiting |
NCT03896958 -
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
|
||
| Completed |
NCT05030090 -
Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer
|
N/A | |
| Terminated |
NCT00669136 -
Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
|
Phase 1 | |
| Recruiting |
NCT04258813 -
Onco-primary Care Networking to Support TEAM-based Care
|
N/A | |
| Completed |
NCT03299036 -
Drug-loadable（T-ACE Beads）for Hepatoma Embolization Therapy
|
N/A | |
| Recruiting |
NCT03323996 -
Impact of a Training in Therapeutic Education on the Relation Between Care Givers and Their Patients
|
N/A | |
| Completed |
NCT02044224 -
Effects of Dexmedetomidine During IRE Procedures for Solid Tumours
|
Phase 4 | |
| Not yet recruiting |
NCT03607643 -
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
|
Phase 1/Phase 2 | |
| Completed |
NCT05643833 -
Impact of Gender on the Outcome of Liver Transplantation for Hepatocellular Carcinoma
|
||
| Recruiting |
NCT03452774 -
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
|
||
| Not yet recruiting |
NCT03766776 -
Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC)
|
N/A | |
| Completed |
NCT02016391 -
Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours
|
Phase 4 | |
| Recruiting |
NCT00730860 -
Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE
|
N/A | |
| Terminated |
NCT00216437 -
Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma
|
Phase 1 | |
| Completed |
NCT04172714 -
Low-dose Y90 Treatment Planning for HCC
|
N/A | |
| Active, not recruiting |
NCT03347162 -
Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer
|
||
| Completed |
NCT05907772 -
Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma
|